Combined ethanol extract of grape Pomace and Omija fruit ameliorates adipogenesis, hepatic steatosis, and inflammation in diet-induced obese mice

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Cho, Su Jung ^a   Jung, Un Ju ^a   Park, Hae Jin ^a   Kim, Hye Jin ^b   Park, Yong Bok ^a   Kim, Sang Ryong ^a   Choi, Myung Sook ^a  

^a Kyungpook National University   (South Korea)

^b CJ Corporation   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FATTY ACID; GRAPE POMACE ETHANOL EXTRACT; INTERLEUKIN 6; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; OMIJA FRUIT ETHANOL EXTRACT; PLANT EXTRACT; PLASMINOGEN ACTIVATOR INHIBITOR 1; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SIZE; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DIET; FATTY ACID BLOOD LEVEL; FATTY ACID OXIDATION; FATTY LIVER; FRUIT; GENE; GENE EXPRESSION; GRAPE; HORMONE BLOOD LEVEL; INFLAMMATION; LIPID DIET; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; SUPPLEMENTATION; WEIGHT GAIN; WHITE ADIPOSE TISSUE;

EID: 84877298666     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/212139     Document Type: Article

References (55)

1. van der Poorten D., Milner K. L., Hui J., Hodge A., Trenell M. I., Kench J. G., London R., Peduto T., Chisholm D. J., George J., Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology 2008 48 2 449 457 2-s2.0-49649096375 10.1002/hep.22350
2. Katsuki A., Sumida Y., Urakawa H., Gabazza E. C., Murashima S., Maruyama N., Morioka K., Nakatani K., Yano Y., Adachi Y., Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance. Diabetes Care 2003 26 8 2341 2344 2-s2.0-0043025606 10.2337/diacare.26.8.2341 (Pubitemid 36993323)
3. Thomas E. L., Hamilton G., Patel N., O'Dwyer R., Dore C. J., Goldin R. D., Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study. Gut 2005 54 1 122 127 (Pubitemid 40007230)
4. Chan D. C., Watts G. F., Ng T. W. K., Hua J., Song S., Barrett P. H. R., Measurement of liver fat by magnetic resonance imaging: relationships with body fat distribution, insulin sensitivity and plasma lipids in healthy men. Diabetes, Obesity and Metabolism 2006 8 6 698 702 2-s2.0-33749487086 10.1111/j.1463-1326.2005.00543.x (Pubitemid 44515568)
5. Eguchi Y., Eguchi T., Mizuta T., Ide Y., Yasutake T., Iwakiri R., Hisatomi A., Ozaki I., Yamamoto K., Kitajima Y., Kawaguchi Y., Kuroki S., Ono N., Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease. Journal of Gastroenterology 2006 41 5 462 469 2-s2.0-33745401989 10.1007/s00535-006-1790-5 (Pubitemid 43941913)
6. Strable M. S., Ntambi J. M., Genetic control of de novo lipogenesis: role in diet-induced obesity. Critical Reviews in Biochemistry and Molecular Biology 2010 45 3 199 214 2-s2.0-77952863834 10.3109/10409231003667500
7. Llobera A., Cañellas J., Dietary fibre content and antioxidant activity of Manto Negro red grape (Vitis vinifera): pomace and stem. Food Chemistry 2007 101 2 659 666 2-s2.0-33748309458 10.1016/j.foodchem.2006.02.025 (Pubitemid 44333199)
8. Hogan S., Canning C., Sun S., Sun X., Zhou K., Effects of grape pomace antioxidant extract on oxidative stress and inflammation in diet induced obese mice. Journal of Agricultural and Food Chemistry 2010 58 21 11250 11256 2-s2.0-78149327089 10.1021/jf102759e
9. Yunoki K., Sasaki G., Tokuji Y., Kinoshita M., Naito A., Aida K., Ohnishi M., Effect of dietary wine pomace extract and oleanolic acid on plasma lipids in rats fed high-fat diet and its DNA microarray analysis. Journal of Agricultural and Food Chemistry 2008 56 24 12052 12058 2-s2.0-58849107231 10.1021/jf8026217
10. Surwit R. S., Feinglos M. N., Rodin J., Sutherland A., Petro A. E., Opara E. C., Kuhn C. M., Rebuffe-Scrive M., Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. Metabolism 1995 44 5 645 651 2-s2.0-0029065480
11. Huang F., Xiong Y., Xu L., Ma S., Dou C., Sedative and hypnotic activities of the ethanol fraction from Fructus Schisandrae in mice and rats. Journal of Ethnopharmacology 2007 110 3 471 475 2-s2.0-33847751050 10.1016/j.jep.2006.10.008 (Pubitemid 46386359)
12. Lau C. H., Chan C. M., Chan Y. W., Lau K. M., Lau T. W., Lam F. C., Che C. T., Leung P. C., Fung K. P., Ho Y. Y., Lau C. B. S., In vitro antidiabetic activities of five medicinal herbs used in Chinese medicinal formulae. Phytotherapy Research 2008 22 10 1384 1388 2-s2.0-55449119881 10.1002/ptr.2513
13. Lee S. W., Yoo J. H., Lee S. K., Keum K. S., Ryu D. G., Kwon K. B., Taeyeumjoweetang affects body weight and obesity-related genes in mice. Evidence-based Complementary and Alternative Medicine 2009 6 1 81 86 2-s2.0-70350647631 10.1093/ecam/nep098
14. Lim Y. T., Lee J. M., Effects of Taeyumjoweetang herbal acupuncture on plasma and liver lipid composition and antioxidative capacity in rat fed high fat diet. The Korean Journal of Meridian and Acupoint 2005 22 151 161
15. Na M., Hung T. M., Oh W. K., Min B. S., Lee S. H., Bae K., Fatty acid synthase inhibitory activity of dibenzocyclooctadiene lignans isolated from Schisandra chinensis. Phytotherapy Research 2010 24 supplement 2 S225 S228 2-s2.0-77953899449 10.1002/ptr.3149
16. Folch J., Lees M., Stanley G. H. S., A simple method for the isolation and purification of total lipides from animal tissues. The Journal of biological chemistry 1957 226 1 497 509 2-s2.0-70449158340
17. Hulcher F. H., Oleson W. H., Simplified spectrophotometric assay for microsomal 3 hydroxy 3 methylglutaryl CoA reductase by measurement of coenzyme A. Journal of Lipid Research 1973 14 6 625 631 2-s2.0-0015911095
18. Lazarow P. B., Assay of peroxisomal β -oxidation of fatty acids. Methods in Enzymolog 1981 72 315 319
19. Ma X. J., Salati L. M., Ash S. E., Mitchell D. A., Klautky S. A., Fantozzi D. A., Goodridge A. G., Nutritional regulation and tissue-specific expression of the malic enzyme gene in the chicken. Transcriptional control and chromatin structure. Journal of Biological Chemistry 1990 265 30 18435 18441 2-s2.0-0025107501
20. Sul H. S., Wang D., Nutritional and hormonal regulation of enzymes in fat synthesis: studies of fatty acid synthase and mitochondrial glycerol-3-phosphate acyltransferase gene transcription. Annual Review of Nutrition 1998 18 331 351 2-s2.0-0031845136 10.1146/annurev.nutr.18.1.331 (Pubitemid 28366871)
21. Merkel M., Eckel R. H., Goldberg I. J., Lipoprotein lipase: genetics, lipid uptake, and regulation. Journal of Lipid Research 2002 43 12 1997 2006 2-s2.0-0036906508 10.1194/jlr.R200015-JLR200 (Pubitemid 35471065)
22. Yang Z. H., Miyahara H., Takeo J., Katayama M., Diet high in fat and sucrose induces rapid onset of obesity-related metabolic syndrome partly through rapid response of genes involved in lipogenesis, insulin signalling and inflammation in mice. Diabetology & Metabolic Syndrome 2012 4 1, article 32
23. Clemente-Postigo M., Queipo-Ortuño M. I., Fernandez-Garcia D., Gomez-Huelgas R., Tinahones F. J., Cardona F., Adipose tissue gene expression of factors related to lipid processing in obesity. PLoS One 2011 6 9, article e24783
24. Weinstock P. H., Levak-Frank S., Hudgins L. C., Radner H., Friedman J. M., Zechner R., Breslow J. L., Lipoprotein lipase controls fatty acid entry into adipose tissue, but fat mass is preserved by endogenous synthesis in mice deficient in adipose tissue lipoprotein lipase. Proceedings of the National Academy of Sciences of the United States of America 1997 94 19 10261 10266 2-s2.0-0030931962 10.1073/pnas.94.19.10261 (Pubitemid 27407029)
25. Gregoire F. M., Smas C. M., Sul H. S., Understanding adipocyte differentiation. Physiological Reviews 1998 78 3 783 809 2-s2.0-0031821520 (Pubitemid 28340604)
26. Yoo J. H., Lee E. J., Kwak C. K., Sohn E. H., Koh B. H., Song I. B., Lee K. S., Clinical trial of herbal formula on weight loss in obese Korean children. The American Journal of Chinese Medicine 2005 33 5 713 722 2-s2.0-24944455779 10.1142/S0192415X0500334X (Pubitemid 41319921)
27. Park S., Park J. S., Cheon C., Yang Y. J., An C., Jang B. H., Song Y. K., Go H., Lee J. A., Shin Y., Ko S. G., A pilot study to evaluate the effect of Taeumjowi-tang on obesity in Korean adults: study protocol for a randomised, double-blind, placebo-controlled, multicentre trial. Trials 2012 13 article 33
28. Trayhurn P., Wood I. S., Adipokines: inflammation and the pleiotropic role of white adipose tissue. The British Journal of Nutrition 2004 92 3 347 355 2-s2.0-6944237757 10.1079/BJN20041213 (Pubitemid 40277057)
29. Bastelica D., Morange P., Berthet B., Borghi H., Lacroix O., Grino M., Juhan-Vague I., Alessi M. C., Stromal cells are the main plasminogen activator inhibitor-1-producing cells in human fat: evidence of differences between visceral and subcutaneous deposits. Arteriosclerosis, Thrombosis, and Vascular Biology 2002 22 1 173 178 2-s2.0-0036144672 10.1161/hq0102.101552 (Pubitemid 34076250)
30. Ouchi N., Parker J. L., Lugus J. J., Walsh K., Adipokines in inflammation and metabolic disease. Nature Reviews Immunology 2011 11 2 85 97 2-s2.0-79151484704 10.1038/nri2921
31. Christiansen T., Richelsen B., Bruun J. M., Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. International Journal of Obesity 2005 29 1 146 150 2-s2.0-11244302456 10.1038/sj.ijo.0802839 (Pubitemid 40065478)
32. Monzillo L. U., Hamdy O., Horton E. S., Ledbury S., Mullooly C., Jarema C., Porter S., Ovalle K., Moussa A., Mantzoros C. S., Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance. Obesity Research 2003 11 9 1048 1054 2-s2.0-1542705365 (Pubitemid 41151581)
33. Hämäläinen H., Rönnemaa T., Virtanen A., Lindström J., Eriksson J. G., Valle T. T., Ilanne-Parikka P., Keinänen-Kiukaanniemi S., Rastas M., Aunola S., Uusitupa M., Tuomilehto J., Improved fibrinolysis by an intensive lifestyle intervention in subjects with impaired glucose tolerance. The Finnish Diabetes Prevention Study. Diabetologia 2005 48 11 2248 2253 2-s2.0-27744600828 10.1007/s00125-005-1938-5 (Pubitemid 41618914)
34. He G., Pedersen S. B., Bruun J. M., Lihn A. S., Jensen P. F., Richelsen B., Differences in plasminogen activator inhibitor 1 in subcutaneous versus omental adipose tissue in non-obese and obese subjects. Hormone and Metabolic Research 2003 35 3 178 182 2-s2.0-0038631787 10.1055/s-2003-39078 (Pubitemid 36577860)
35. Winkler G., Kiss S., Keszthelyi L., Sápi Z., Öry I., Salamon F., Kovács M., Vargha P., Szekeres O., Speer G., Karádi I., Sikter M., Kaszás E., Dworak O., Gerö G., Cseh K., Expression of tumor necrosis factor (TNF)- protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF- soluble serum TNF-receptor-2 concentrations and C-peptide level. The European Journal of Endocrinology 2003 149 2 129 135 2-s2.0-0042025075 10.1530/eje.0.1490129 (Pubitemid 36987155)
36. Maury E., Ehala-Aleksejev K., Guiot Y., Detry R., Vandenhooft A., Brichard S. M., Adipokines oversecreted by omental adipose tissue in human obesity. American Journal of Physiology 2007 293 3 E656 E665 2-s2.0-34548448415 10.1152/ajpendo.00127.2007 (Pubitemid 47358976)
37. Bruun J. M., Lihn A. S., Pedersen S. B., Richelsen B., Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. Journal of Clinical Endocrinology and Metabolism 2005 90 4 2282 2289 2-s2.0-17844393870 10.1210/jc.2004-1696 (Pubitemid 40586275)
38. Maachi M., Piéroni L., Bruckert E., Jardel C., Fellahi S., Hainque B., Capeau J., Bastard J. P., Systemic low-grade inflammation is related to both circulating and adipose tissue TNF leptin and IL-6 levels in obese women. International Journal of Obesity 2004 28 8 993 997 2-s2.0-3242889982 10.1038/sj.ijo.0802718 (Pubitemid 38998704)
39. Takahashi K., Mizuarai S., Araki H., Mashiko S., Ishihara A., Kanatani A., Itadani H., Kotani H., Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice. Journal of Biological Chemistry 2003 278 47 46654 46660 2-s2.0-0344443732 10.1074/jbc.M309895200 (Pubitemid 37452242)
40. Batista M. L. Jr., Peres S. B., McDonald M. E., Alcantara P. S., Olivan M., Otoch J. P., Farmer S. R., Seelaender M., Adipose tissue inflammation and cancer cachexia: possible role of nuclear transcription factors. Cytokine 2012 57 1 9 16
41. Calamita G., Portincasa P., Present and future therapeutic strategies in non-alcoholic fatty liver disease. Expert Opinion on Therapeutic Targets 2007 11 9 1231 1249 2-s2.0-34548819916 10.1517/14728222.11.9.1231 (Pubitemid 47527327)
42. Schäffler A., Schölmerich J., Büchler C., Mechanisms of disease: adipocytokines and visceral adipose tissue-emerging role in nonalcoholic fatty liver disease. Nature Clinical Practice Gastroenterology & Hepatology 2005 2 6 273 280 (Pubitemid 40895403)
43. Donnelly K. L., Smith C. I., Schwarzenberg S. J., Jessurun J., Boldt M. D., Parks E. J., Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. Journal of Clinical Investigation 2005 115 5 1343 1351 2-s2.0-18244382304 10.1172/JCI200523621 (Pubitemid 40629054)
44. Mavrelis P. G., Ammon H. V., Gleysteen J. J., Komorowski R. A., Charaf U. K., Hepatic free fatty acids in alcoholic liver disease and morbid obesity. Hepatology 1983 3 2 226 231 2-s2.0-0020665065 (Pubitemid 13165374)
45. Larter C. Z., Yeh M. M., Haigh W. G., Williams J., Brown S., Bell-Anderson K. S., Lee S. P., Farrell G. C., Hepatic free fatty acids accumulate in experimental steatohepatitis: role of adaptive pathways. Journal of Hepatology 2008 48 4 638 647 2-s2.0-39849103404 10.1016/j.jhep.2007.12.011
46. Medina-Gomez G., Gray S. L., Yetukuri L., Shimomura K., Virtue S., Campbell M., Curtis R. K., Jimenez-Linan M., Blount M., Yeo G. S., Lopez M., Seppänen-Laakso T., Ashcroft F. M., Oresic M., Vidal-Puig A., PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS genetics 2007 3 4, article e64 2-s2.0-34249848988 10.1371/journal.pgen.0030064 (Pubitemid 46683479)
47. Schulz H., Regulation of fatty acid oxidation in heart. Journal of Nutrition 1994 124 2 165 171 2-s2.0-0028293731 (Pubitemid 24093954)
48. Tsochatzis E., Papatheodoridis G. V., Archimandritis A. J., The evolving role of leptin and adiponectin in chronic liver diseases. The American Journal of Gastroenterology 2006 101 11 2629 2640 2-s2.0-33750522030 10.1111/j.1572-0241.2006.00848.x (Pubitemid 44665263)
49. Cai D., Yuan M., Frantz D. F., Melendez P. A., Hansen L., Lee J., Shoelson S. E., Local and systemic insulin resistance resulting from hepatic activation of IKK- β and NF- B. Nature Medicine 2005 11 2 183 190 2-s2.0-14644427890 10.1038/nm1166 (Pubitemid 40321354)
50. Tarantino G., Conca P., Pasanisi F., Ariello M., Mastrolia M., Arena A., Tarantino M., Scopacasa F., Vecchione R., Could inflammatory markers help diagnose nonalcoholic steatohepatitis? The European Journal of Gastroenterology and Hepatology 2009 21 5 504 511 2-s2.0-63849339897 10.1097/MEG.0b013e3283229b40
51. Endo M., Masaki T., Seike M., Yoshimatsu H., TNF- induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c). Experimental Biology and Medicine 2007 232 5 614 621 2-s2.0-34247604581 (Pubitemid 46683386)
52. Choi S. S., Diehl A. M., Hepatic triglyceride synthesis and nonalcoholic fatty liver disease. Current Opinion in Lipidology 2008 19 3 295 300 2-s2.0-43249092409 10.1097/MOL.0b013e3282ff5e55 (Pubitemid 351653569)
53. Li Z., Yang S., Lin H., Huang J., Watkins P. A., Moser A. B., DeSimone C., Song X. Y., Diehl A. M., Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 2003 37 2 343 350 2-s2.0-0037309589 10.1053/jhep.2003.50048 (Pubitemid 36152533)
54. Tomita K., Tamiya G., Ando S., Ohsumi K., Chiyo T., Mizutani A., Kitamura N., Toda K., Kaneko T., Horie Y., Han J. Y., Kato S., Shimoda M., Oike Y., Tomizawa M., Makino S., Ohkura T., Saito H., Kumagai N., Nagata H., Ishii H., Hibi T., Tumour necrosis factor signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice. Gut 2006 55 3 415 424 2-s2.0-33144463511 10.1136/gut.2005.071118 (Pubitemid 43268283)
55. Bacon B. R., Farahvash M. J., Janney C. G., Neuschwander-Tetri B. A., Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994 107 4 1103 1109 (Pubitemid 24294573)